Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > EV / EBITDA (ntm)

Amag Pharmaceuticals EV / EBITDA (ntm) Chart (AMAG)

Amag Pharmaceuticals annual/quarterly EV / EBITDA (ntm) from 2014 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Amag Pharmaceuticals EV / EBITDA (ntm) for the quarter ending October 10, 2020 was 19.51 a 1.04% increase of 0.20 year over year
  • Amag Pharmaceuticals EV / EBITDA (ntm) for the last 12 months ending October 10, 2020 was 19.51 a 1.04% increase of 0.20 year over year
  • Amag Pharmaceuticals Annual EV / EBITDA (ntm) for 2020 was 19.51 a 0.05% increase of 0.01 from 2019
  • Amag Pharmaceuticals Annual EV / EBITDA (ntm) for 2020 was 19.50 a -0.05% decrease of -0.01 from 2019
  • Amag Pharmaceuticals Annual EV / EBITDA (ntm) for 2020 was 19.51 a 1.04% increase of 0.20 from 2019
Other Valuation Metrics:
  • Amag Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $687m a 6.12% increase of 42m year over year
  • Amag Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 0.87 a 21.08% increase of 0.18 year over year
  • Amag Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,093m a 1.93% increase of 21m year over year
View Chart On Koyfin

Quarterly AMAG EV / EBITDA (ntm) Data

10/202019.51
10/202019.50
10/202019.51
10/202019.31
10/202019.22
10/202019.19
10/202019.18
10/202019.20
10/202019.19
10/202018.87

Annual AMAG EV / EBITDA (ntm) Data

202019.51
202019.50
202019.51
202019.31
202019.22
202019.19
202019.18
202019.20
202019.19
202018.87